{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:04:47Z","timestamp":1771268687140,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T00:00:00Z","timestamp":1190937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s10549-007-9729-y","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T09:36:29Z","timestamp":1190885789000},"page":"377-385","source":"Crossref","is-referenced-by-count":35,"title":["G1738R is a BRCA1 founder mutation in Greek breast\/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history"],"prefix":"10.1007","volume":"110","author":[{"given":"Theodore","family":"Anagnostopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maroulio","family":"Pertesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Konstantopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Armaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smaragda","family":"Kamakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Nasioulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanassios","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Dobrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Anne","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,28]]},"reference":[{"key":"9729_CR1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM et\u00a0al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087\u20131093","journal-title":"Nature"},{"key":"9729_CR2","first-page":"189","volume":"57","author":"P Tonin","year":"1995","unstructured":"Tonin P, Serova O, Lenoir G et\u00a0al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189","journal-title":"Am J Hum Genet"},{"key":"9729_CR3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jmg.33.10.814","volume":"33","author":"F Durocher","year":"1996","unstructured":"Durocher F, Tonin P, Shattuck-Eidens D et\u00a0al (1996) Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet 33:814\u2013819","journal-title":"J Med Genet"},{"key":"9729_CR4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/302099","volume":"63","author":"PN Tonin","year":"1998","unstructured":"Tonin PN, Mes-Masson AM, Futreal PA et\u00a0al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63:1341\u20131351","journal-title":"Am J Hum Genet"},{"key":"9729_CR5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0959-8049(99)00050-7","volume":"35","author":"A Dorum","year":"1999","unstructured":"Dorum A, Hovig E, Trope C et\u00a0al (1999) Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 35:779\u2013781","journal-title":"Eur J Cancer"},{"key":"9729_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000472203","volume":"4","author":"T Peelen","year":"1996","unstructured":"Peelen T, Cornelis RS, van Vliet M et\u00a0al (1996) The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet 4:225\u2013230","journal-title":"Eur J Hum Genet"},{"key":"9729_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M et\u00a0al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341\u2013345","journal-title":"Nat Genet"},{"key":"9729_CR8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20162","volume":"110","author":"B Gorski","year":"2004","unstructured":"Gorski B, Jakubowska A, Huzarski T et\u00a0al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683\u2013686","journal-title":"Int J Cancer"},{"key":"9729_CR9","doi-asserted-by":"crossref","unstructured":"Konstantopoulou I, Rampias T, Ladopoulou A et\u00a0al (2007) Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast\/ovarian cancer patients. Breast Cancer Res Treat [Epub ahead of print]","DOI":"10.1007\/s10549-007-9571-2"},{"key":"9729_CR10","doi-asserted-by":"crossref","first-page":"53007","DOI":"10.1074\/jbc.M310182200","volume":"278","author":"RS Williams","year":"2003","unstructured":"Williams RS, Chasman DI, Hau DD et\u00a0al (2003) Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J Biol Chem 278:53007\u201353016","journal-title":"J Biol Chem"},{"key":"9729_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10689-005-2579-z","volume":"5","author":"JN Glover","year":"2006","unstructured":"Glover JN (2006) Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain. Fam Cancer 5:89\u201393","journal-title":"Fam Cancer"},{"key":"9729_CR12","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1158\/0008-5472.CAN-03-3009","volume":"64","author":"N Mirkovic","year":"2004","unstructured":"Mirkovic N, Marti-Renom MA, Weber BL et\u00a0al (2004) Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res 64:3790\u20133797","journal-title":"Cancer Res"},{"key":"9729_CR13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","volume":"66","author":"G Chenevix-Trench","year":"2006","unstructured":"Chenevix-Trench G, Healey S, Lakhani S et\u00a0al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66:2019\u20132027","journal-title":"Cancer Res"},{"key":"9729_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1101\/gad.959202","volume":"16","author":"WS Joo","year":"2002","unstructured":"Joo WS, Jeffrey PD, Cantor SB et\u00a0al (2002) Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev 16:583\u2013593","journal-title":"Genes Dev"},{"key":"9729_CR15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","volume":"41","author":"V Abkevich","year":"2004","unstructured":"Abkevich V, Zharkikh A, Deffenbaugh AM et\u00a0al (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41:492\u2013507","journal-title":"J Med Genet"},{"key":"9729_CR16","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pcbi.0030026","volume":"3","author":"R Karchin","year":"2007","unstructured":"Karchin R, Monteiro AN, Tavtigian SV et\u00a0al (2007) Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol 3:e26","journal-title":"PLoS Comput Biol"},{"key":"9729_CR17","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-06-3297","volume":"67","author":"MA Carvalho","year":"2007","unstructured":"Carvalho MA, Marsillac SM, Karchin R et\u00a0al (2007) Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res 67:1494\u20131501","journal-title":"Cancer Res"},{"key":"9729_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM et\u00a0al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535\u2013544","journal-title":"Am J Hum Genet"},{"key":"9729_CR19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215","journal-title":"Nucleic Acids Res"},{"key":"9729_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3835(01)00845-X","volume":"185","author":"A Ladopoulou","year":"2002","unstructured":"Ladopoulou A, Kroupis C, Konstantopoulou I et\u00a0al (2002) Germ line BRCA1 and BRCA2 mutations in Greek breast\/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett 185:61\u201370","journal-title":"Cancer Lett"},{"key":"9729_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejca.2006.09.021","volume":"43","author":"S Armaou","year":"2007","unstructured":"Armaou S, Konstantopoulou I, Anagnostopoulos T et\u00a0al (2007) Novel genomic rearrangements in the BRCA1 gene detected in Greek breast\/ovarian cancer patients. Eur J Cancer 43:443\u2013453","journal-title":"Eur J Cancer"},{"key":"9729_CR22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/378100","volume":"73","author":"D Thompson","year":"2003","unstructured":"Thompson D, Easton DF, Goldgar DE (2003) A full-likelihood method for the evaluation of causality of sequence variants from family data. Am J Hum Genet 73:652\u2013655","journal-title":"Am J Hum Genet"},{"key":"9729_CR23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et\u00a0al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9729_CR24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/301885","volume":"62","author":"SL Neuhausen","year":"1998","unstructured":"Neuhausen SL, Godwin AK, Gershoni-Baruch R et\u00a0al (1998) Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 62:1381\u20131388","journal-title":"Am J Hum Genet"},{"key":"9729_CR25","first-page":"271","volume":"58","author":"SL Neuhausen","year":"1996","unstructured":"Neuhausen SL, Mazoyer S, Friedman L et\u00a0al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271\u2013280","journal-title":"Am J Hum Genet"},{"key":"9729_CR26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/hmg\/2.8.1123","volume":"2","author":"JL Weber","year":"1993","unstructured":"Weber JL, Wong C (1993) Mutation of human short tandem repeats. Hum Mol Genet 2:1123\u20131128","journal-title":"Hum Mol Genet"},{"key":"9729_CR27","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1158\/0008-5472.CAN-05-1241","volume":"65","author":"T Judkins","year":"2005","unstructured":"Judkins T, Hendrickson BC, Deffenbaugh AM et\u00a0al (2005) Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res 65:10096\u201310103","journal-title":"Cancer Res"},{"key":"9729_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-2836(02)00478-3","volume":"320","author":"CM Ekblad","year":"2002","unstructured":"Ekblad CM, Wilkinson HR, Schymkowitz JW et\u00a0al (2002) Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1. J Mol Biol 320:431\u2013442","journal-title":"J Mol Biol"},{"key":"9729_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2004.09.014","volume":"114","author":"S Pyrpassopoulos","year":"2005","unstructured":"Pyrpassopoulos S, Ladopoulou A, Vlassi M et\u00a0al (2005) Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1. Biophys Chem 114:1\u201312","journal-title":"Biophys Chem"},{"key":"9729_CR30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nsmb776","volume":"11","author":"RS Williams","year":"2004","unstructured":"Williams RS, Lee MS, Hau DD et\u00a0al (2004) Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat Struct Mol Biol 11:519\u2013525","journal-title":"Nat Struct Mol Biol"},{"key":"9729_CR31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbapap.2007.03.018","volume":"1774","author":"G Nikolopoulos","year":"2007","unstructured":"Nikolopoulos G, Pyrpassopoulos S, Thanassoulas A et\u00a0al (2007) Thermal unfolding of human BRCA1 BRCT-domain variants. Biochim Biophys Acta 1774:772\u2013780","journal-title":"Biochim Biophys Acta"},{"key":"9729_CR32","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/302358","volume":"64","author":"X Liu","year":"1999","unstructured":"Liu X, Barker DF (1999) Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. Am J Hum Genet 64:1427\u20131439","journal-title":"Am J Hum Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9729-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:54Z","timestamp":1559233734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,28]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["9729"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9729-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,28]]}}}